ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,994.57
      -0.76%
      US Tech 100
      20,685.20
      -0.19%
      Dow Jones
      44,421.91
      -0.28%
      Brent Oil
      74.95
      -0.54%
      Bitcoin
      98,417.54
      -2.96%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Fluidigm Corporation (FLDM) Quote

      Fluidigm Corporation

      Fluidigm Corporation (FLDM)

      Franklin International Multifactor Index ETF
      3.71
      0.00
      (0.00%)
      Closed February 03 4:00PM
      Delayed by 15 minutes
      3.71
      0.00
      ( 0.00% )
      Pre Market: 7:00PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      3.71
      Bid
      3.69
      Ask
      4.03
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      294.555M
      Previous Close
      3.71
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      79,395,000
      Dividend Yield
      -
      PE Ratio
      -3.95
      Earnings Per Share (EPS)
      -0.94
      Revenue
      106.34M
      Net Profit
      -74.66M

      About Fluidigm Corporation

      Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies. It sells instruments and consumables, including integrated fluidic circuits, assays, and reagents. Sl... Fluidigm Corp manufactures life science tools focused on the analysis of single cells and industrial applications of genomics. These tools are based on microfluidics and mass cytometry technologies. It sells instruments and consumables, including integrated fluidic circuits, assays, and reagents. Slightly more than half of the firm's revenue comes from the sale of Consumables. Fluidigm primarily sells its products to academic institutions, clinical laboratories, and biopharmaceutical companies. The majority of revenue is generated in the United States followed by EMEA and Asia-Pacific. Show more

      Sector
      Lab Analytical Instruments
      Industry
      Lab Analytical Instruments
      Website
      www.fluidigm.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      FLDM Latest News

      More News

      Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.

      New Trading Symbol (NASDAQ:LAB) Expected to be Effective April 6, 2022 Appoints New Management Team and Additional Board Members with Significant Experience to Reinvigorate Growth and Enhance...

      April 04 2022
      GlobeNewswire Inc.

      Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion

      SOUTH SAN FRANCISCO, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM) today announced that its stockholders have voted to approve all of the proposals related to the...

      April 01 2022
      GlobeNewswire Inc.

      Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global

      Caligan Partners to Vote “FOR” Casdin and Viking Transaction and All Other Fluidigm Proposals at the Special Meeting to be Reconvened on April 1, 2022 Fluidigm Board to Appoint Frank Witney, a...

      March 29 2022
      GlobeNewswire Inc.

      Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution

      Company Urges ALL Stockholders to Vote “FOR” the Proposals at the Special Meeting Parties to Terminate the Purchase Agreements if Stockholder Approval is Not Received on April 1 SOUTH SAN...

      March 28 2022
      GlobeNewswire Inc.

      Fluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022

      SOUTH SAN FRANCISCO, Calif., March 25, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it convened and then adjourned, without conducting any other business, the...

      March 25 2022
      GlobeNewswire Inc.

      Fluidigm Urges Stockholders to Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion TODAY

      SOUTH SAN FRANCISCO, Calif., March 21, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today urged Fluidigm stockholders to vote “FOR” ALL proposals related to the previously...

      March 21 2022
      GlobeNewswire Inc.

      Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion

      SOUTH SAN FRANCISCO, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), today announced that leading independent proxy advisory firms Institutional Shareholder...

      March 17 2022
      GlobeNewswire Inc.

      Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results 

      SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...

      February 17 2022
      GlobeNewswire Inc.

      Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies

      SOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...

      February 17 2022
      GlobeNewswire Inc.

      Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global Investors

      SOUTH SAN FRANCISCO, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM) today filed with the U.S. Securities and Exchange Commission (the “SEC”) a preliminary proxy...

      February 14 2022
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      FLDM - Frequently Asked Questions (FAQ)

      What is the current Fluidigm share price?
      The current share price of Fluidigm is $ 3.71
      How many Fluidigm shares are in issue?
      Fluidigm has 79,395,000 shares in issue
      What is the market cap of Fluidigm?
      The market capitalisation of Fluidigm is USD 294.56M
      What is the 1 year trading range for Fluidigm share price?
      Fluidigm has traded in the range of $ 0.00 to $ 0.00 during the past year
      What is the PE ratio of Fluidigm?
      The price to earnings ratio of Fluidigm is -3.95
      What is the cash to sales ratio of Fluidigm?
      The cash to sales ratio of Fluidigm is 2.77
      What is the reporting currency for Fluidigm?
      Fluidigm reports financial results in USD
      What is the latest annual turnover for Fluidigm?
      The latest annual turnover of Fluidigm is USD 106.34M
      What is the latest annual profit for Fluidigm?
      The latest annual profit of Fluidigm is USD -74.66M
      What is the registered address of Fluidigm?
      The registered address for Fluidigm is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Fluidigm website address?
      The website address for Fluidigm is www.fluidigm.com
      Which industry sector does Fluidigm operate in?
      Fluidigm operates in the LAB ANALYTICAL INSTRUMENTS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      EVAXEvaxion Biotech AS
      $ 4.09
      (70.42%)
      		6.41M
      TNFATNF Pharmaceuticals Inc
      $ 0.98
      (34.62%)
      		100
      PTIRGraniteShares 2X Long PLTR Daily ETF
      $ 208.07
      (33.97%)
      		47.9k
      PLTUDirexion DAily PLTR Bull 2X Shares
      $ 44.03
      (33.46%)
      		59.98k
      IVVDInvivyd Inc
      $ 1.36
      (28.30%)
      		6.43M
      UOKAMDJM Ltd
      $ 0.173
      (-27.31%)
      		471.52k
      BCTXBriaCell Therapeutics Corporation
      $ 3.71
      (-26.39%)
      		11.93k
      EJHE Home Household Service Holdings Ltd
      $ 0.7652
      (-24.98%)
      		35.37k
      TENXTenax Therapeutics Inc
      $ 4.48
      (-24.71%)
      		98
      UPCUniverse Pharmaceuticals Inc
      $ 0.315
      (-24.53%)
      		24.62k
      IVVDInvivyd Inc
      $ 1.36
      (28.30%)
      		6.43M
      EVAXEvaxion Biotech AS
      $ 4.09
      (70.42%)
      		6.41M
      BHATBlue Hat Interactive Entertainment Technology
      $ 0.041
      (-11.26%)
      		2.02M
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.1655
      (-15.08%)
      		1.95M
      RIMEAlgorhythm Holdings Inc
      $ 0.0271
      (1.50%)
      		1.61M

      FLDM Discussion

      View Posts
      manysevens manysevens 3 years ago
      FLDM bot this 30 min chart today..

      👍️0
      Eggplant Eggplant 3 years ago
      No. I think they are in deep doo doo. They just held their Q3 conference call, and took ZERO questions. What's that about? I think that level of silence speaks volumes. It looks like they are burning more than $10m of cash a quarter, with only $30m of cash remaining - but it's really only $20m if you net out the $10m of cash borrowed from Silicon Valley Bank term loan during the quarter. The working capital #'s are starting to look a bit strange: sales down, and A/R down commensurately, BUT Inventories UP, and A/P UP! It sure looks like they are stretching their payables. Who wants to do the A/P days calculation? Who wants to read the SVB loan agreement to see if covenants were tripped, or will be shortly?

      On 7/27/21 Bloomberg reported that FLDM was working with an advisor and speaking to potential buyers of the company. That was 3 months ago, and: nothing. So today they announce a "Strategic Review . . . to maximize shareholder value". This looks like the trajectory of a distressed company, doesn't it?
      👍️0
      LongTimeObserver LongTimeObserver 4 years ago
      $FLDM Back from the dead?
      👍️0
      LongTimeObserver LongTimeObserver 4 years ago
      Pffft! $FLDM
      👍️0
      Atlanta1 Atlanta1 4 years ago
      06:28
      $FLDM
      Fluidigm: Trump Administration provides saliva test at surge testing site in Waco, TX (6.75)
      "Starting today, communities that are part of the federal surge testing effort for COVID-19, supported by the Trump Administration, have a new option: a test that uses samples of saliva collected by spitting into a sterile container. Made by Fluidigm Corporation and supported in part by the National Institutes of Health (NIH), the easy-to-use saliva test detects SARS-CoV-2, the virus that causes COVID-19, on a molecular level using a microfluidics platform. The accuracy of the test is comparable to other molecular-level tests of nasal swab samples, according to a clinical study conducted by the manufacturer. The U.S. Department of Health and Human Services (HHS) has traditionally provided nasal swab tests from other manufacturers to surge testing sites, which remain a choice for community officials."

      https://www.hhs.gov/about/news/2020/10/16/trump-administration-provides-saliva-test-at-surge-testing-site-in-waco-tx.html
      👍️0
      Ckasper Ckasper 4 years ago
      Don’t want to jinx it, but currently the stock is up 90%. Hope that means we’ll see a big gap opening tomorrow.
      👍️0
      Ckasper Ckasper 4 years ago
      Does anybody know, when they are expecting the NHI approval and what is still open regarding the approval?
      👍️0
      lakingsphan0427 lakingsphan0427 4 years ago
      The retarded Newscum of Khalifhurnia should do the same..

      Patience is the key here..
      👍️0
      Hole shot King Hole shot King 4 years ago
      Fluidigm Corporation (Nasdaq: $FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced progress on the Company’s Rapid Acceleration of Diagnostics (RADx) project.

      https://ih.advfn.com/stock-market/NASDAQ/fluidigm-FLDM/stock-news/83214731/fluidigm-achieves-initial-milestone-under-nih-rapi
      👍️0
      Hole shot King Hole shot King 4 years ago
      8K Item 8.01. Other Events.



      From August 13, 2020 through September 3, 2020, Fluidigm Corporation (the “Company”) sold a total of 2,479,517 shares of its common stock for aggregate gross proceeds of approximately $20.9 million before commissions and offering expenses under its previously announced “at-the-market” equity offering program. The sales were completed pursuant to the Open Market Sale AgreementSM with Jefferies LLC dated as of March 4, 2020, which the Company filed as an exhibit to a Current Report on Form 8-K filed with the Securities and Exchange Commission on March 5, 2020.


      https://ih.advfn.com/stock-market/NASDAQ/fluidigm-FLDM/stock-news/83213327/current-report-filing-8-k
      👍️0
      Ckasper Ckasper 4 years ago
      NEWS OUT.
      FLDM fulfills first step of NHI requirements.
      👍️0
      Hole shot King Hole shot King 4 years ago
      The Law Offices of Frank R. Cruz Announces Investigation of Fluidigm Corporation (FLDM) on Behalf of Investors $FLDM https://newsfilter.io/a/0a76fc698a3e38b64c511d5e5683326e
      👍️0
      Hole shot King Hole shot King 4 years ago
      $FLDM should have a good bounce
      👍️0
      Ckasper Ckasper 4 years ago
      Keep it coming. Gotta be patient
      👍️0
      Hole shot King Hole shot King 4 years ago
      $FLDM Gov of Missouri is working in the "coming weeks" to roll out the saliva based test to all Missouri citizens
      👍️0
      Hole shot King Hole shot King 4 years ago
      $FLDM Governor to talk saliva-based COVID-19 test https://www.newspressnow.com/news/regional_news/central_missouri/governor-to-talk-saliva-based-covid-19-test/article_aa493c13-9d63-561b-a78c-e66218ec79e4.html?utm_medium=social&utm_source=twitter&utm_campaign=user-share via @newspressnow
      👍️0
      Ckasper Ckasper 4 years ago
      Quick testing is still highly demanded. Especially with schools starting now.
      👍️0
      jonsmile jonsmile 4 years ago
      Not sure it might be over it’s all about the cure now
      👍️0
      Ckasper Ckasper 4 years ago
      Agree. That’s why I’m saying it’s going up from here.
      👍️0
      jonsmile jonsmile 4 years ago
      This entire sector has been down

      OPK as well
      👍️0
      Ckasper Ckasper 4 years ago
      You here for short gains? That streak would be over now ;)
      👍️0
      jonsmile jonsmile 4 years ago
      LOL counting those chickens I see
      👍️0
      Ckasper Ckasper 4 years ago
      For now
      👍️0
      jonsmile jonsmile 4 years ago
      But it’s red LOL
      👍️0
      Ckasper Ckasper 4 years ago
      Today is the turnaround. First Green Day in a week. Up from here.
      👍️0
      Ckasper Ckasper 4 years ago
      They’ll have to bring out news soon. Implementation in colleges and schools would be the perfect news.
      👍️0
      lakingsphan0427 lakingsphan0427 4 years ago
      Added a few more here..
      👍️0
      rstar rstar 4 years ago
      NIH grant monies and full approval coming next i think- also usage data will hopefully show detection earlier than other tests and greater accuracy $FLDM
      👍️0
      Ckasper Ckasper 4 years ago
      It’ll jump next week again, if they bring out an official statement.
      👍️0
      Hole shot King Hole shot King 4 years ago
      $FLDM

      https://twitter.com/DARPA/status/1299367154580627459

      👍️0
      Hole shot King Hole shot King 4 years ago
      $FLDM Interview on Washington University's new Saliva COVID test

      Rich Head, MS, Director, Genome Technology Access Center,
      @GenomeInstitute
      , discusses Fluidigm’s FDA authorization of the new co-developed extraction-free saliva test, run on Fluidigm® Biomark™ HD microfluidics platform, with Fox2 News in St. Louis.


      https://twitter.com/fluidigm/status/1299752445237624839


      👍️0
      lakingsphan0427 lakingsphan0427 4 years ago
      Just added a few more today..
      👍️0
      Ckasper Ckasper 4 years ago
      I like it. Great find
      👍️0
      Hole shot King Hole shot King 4 years ago
      twitter https://www.marketbeat.com/instant-alerts/nasdaq-fldm-a-buy-or-sell-right-now-2020-08/

      https://twitter.com/ZolmaxNews


      https://zolmax.com/investing/fluidigm-nasdaqfldm-price-target-raised-to-16-00-at-ubs-group/4690037.html

      $FLDM
      👍️0
      Ckasper Ckasper 4 years ago
      Where did you see that?
      👍️0
      lakingsphan0427 lakingsphan0427 4 years ago
      Sounds good to me..
      👍️0
      Hole shot King Hole shot King 4 years ago
      Fluidigm $FLDM Price Target Raised to $16.00 at UBS Group
      👍️0
      Ckasper Ckasper 4 years ago
      Hoping for a good post market move, so we can see some additional gain tomorrow.
      👍️0
      Inspector121 Inspector121 4 years ago
      Never stop learning lessons. Priceless.
      👍️0
      Ckasper Ckasper 4 years ago
      I rarely pick it right either, but this was pretty obvious. Thx for the kudos ;)
      👍️0
      Inspector121 Inspector121 4 years ago
      Great call. Wish I had the knowledge to be able to see these things. Thanks
      👍️0
      Inspector121 Inspector121 4 years ago
      Accuracy of that test is questionable. But BP can get away with it. Rigged system. Money talks and FDA listens.
      👍️0
      lakingsphan0427 lakingsphan0427 4 years ago
      WHOA! my $7.65 buys this morning starts to look good..

      $20 or better by end of year..
      👍️0
      Runners123 Runners123 4 years ago
      That was a fleeting moment of hype, now a new test is approved that costs $5 and takes 5 minutes for results.
      👍️0
      Daddy Rick Daddy Rick 4 years ago
      I'm at an avg. of $9.41 and feel good about it.

      Thinking anything under $10.00 is a REALLY GREAT investment here. BWDIK lol
      👍️0
      sfast900 sfast900 4 years ago
      Bittersweet, I was fine with 1000 shares at 10.
      I guess 3200 is what it needed.
      Try to get my shares NOW... LOL
      👍️0
      Ckasper Ckasper 4 years ago
      It’ll bottom at 7.50. Then go back to around 9 in the afternoon.
      👍️0
      Daddy Rick Daddy Rick 4 years ago
      Thank You.
      👍️0
      Inspector121 Inspector121 4 years ago
      Abbott tests highly inaccurate.
      👍️0
      ib12u ib12u 4 years ago
      Is this worth getting into? Looks like it took a fall at the opening..
      👍️0

      Your Recent History

      NASDAQ
      FLDM
      Fluidigm
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads